Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level ≤ 10 ng/ml: Radiation therapy or surgery?
Douglas Keyser, Patrick A. Kupelian, Craig D. Zippe, Howard S. Levin, Eric A. KleinVolume:
38
Year:
1997
Language:
english
Pages:
7
DOI:
10.1016/s0360-3016(97)00123-5
File:
PDF, 740 KB
english, 1997